Maternal vaccination: moving the science forward

Maternal vaccination: moving the science forward.

BACKGROUND Infections remain one of the leading causes of morbidity in pregnant women and newborns, with vaccine-preventable infections contributing significantly to the burden of disease. In the past decade, maternal vaccination has emerged as a promising public health strategy to prevent and combat maternal, fetal and neonatal infections. Despite a number of universally recommended maternal v...

Reply: Maternal vaccination: moving the science forward.

found similar seroconversion rates during the three trimesters of pregnancy (Sperling et al., 2012). Finally, the ability of pregnant women to respond to recall antigens was recently demonstrated in a randomized controlled trial of tetanus–diphtheria–acellular pertussis immunization. The immunogenicity was shown to be similar in pregnant and nonpregnantwomen (Munoz et al., 2014). In summary, B ...

Vitamin D: Moving Forward to Address Emerging Science

The science surrounding vitamin D presents both challenges and opportunities. Although many uncertainties are associated with the understandings concerning vitamin D, including its physiological function, the effects of excessive intake, and its role in health, it is at the same time a major interest in the research and health communities. The approach to evaluating and interpreting the availab...

Moving Forward

.......Having reached the end of my second term as editor in chief, the time has come for Micro to move forward to the next phase of its evolution. I am delighted to announce that Dr. Erik Altman from IBM Research is the new Micro EIC. Erik is an accomplished and highly respected industry architect and researcher who has held numerous leadership positions within the computing community. He has ...

Moving forward.